PointClickCare Gears Up for IPO
PointClickCare has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 249Is There Another 25% Upside in Medtronic?
On Medtronic, Oppenheimer has an Outperform rating and a $86 price target, implying upside of 25% from current prices.
Why Lannett Is Running
Lannett climbed high on Thursday after announcing the signing of a definitive agreement to purchase UCB's generics unit, Kremers Urban, for $1.23 billion.
Q1 Revenue Lifts Medtronic Over Low Earnings Bar
Medtronic reported lower but better-than-expected fiscal first-quarter earnings before the markets opened on Thursday.
Tesaro Rises on Positive FDA Results
Tesaro shares reacted positively in the market Wednesday after positive study results surrounding its lead product were released.
What to Expect From Medtronic Earnings
Medtronic is scheduled to report its fiscal first-quarter financial results on Thursday after the markets close.
Heartware Moves to Acquire Valtech Cardio
Heartware International is looking to continue its strong performance in 2015, and one of the better options that the company sees for growth is an acquisition.
Is the Move in Trevena Sustainable?
Trevena saw its shares continue to climb during Tuesday’s session on news of a positive Phase 2 trial.
Cortendo Prepares for IPO
Cortendo has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
PharMEDium Files for IPO
PharMEDium Healthcare Holdings has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
NovoCure Gears Up for IPO
NovoCure Ltd. Has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Sancilio Pharma Files for IPO
Sancilio Pharmaceuticals has with the Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
What Illumina Gets With GenoLogics Life Science Software
Tuesday morning, Illumina announced the completion of its acquisition of GenoLogics Life Science Software.
Trevena Soars on Positive Phase 2 Results
Trevena watched its shares soar in Monday’s after-hours session on news of a positive Phase 2 trial.
Is the BioLife Move Sustainable?
BioLife Solutions was up solidly in Monday’s trading session on positive results from a Phase 3 study.